Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
5
天
Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026
作者
Norio Akuta; Tomomi Kogiso; Kenichi Ikejima; Motoyuki Otsuka; Takumi Kawaguchi; Miwa Kawanaka; Hirokazu Takahashi; Nobuharu Tamaki; Hayato Nakagawa; Hayato Hikita; Hideki Fujii; Kanji Yamaguchi; Masato Yoneda; Kazuyoshi Kon; Akira Uchiyama; Yuya Seko; Sadatsugu Sakane; Ryuta Shigefuku; Naoto Fujiwara; Michihiro Iwaki; Takashi Kobayashi; Takuya Adachi; Yasuto Takeuchi; Tsubasa Tsutsumi; Dan Nakano; Kaoru Shibayama; Noriyo Urata; Hisamitsu Miyaaki; Hidekatsu Kuroda; Masahiro Koseki; Hirohito Sone; Yasuhiro Matsubayashi; Keisuke Kakisaka; Atsushi Takai; Kazuo Notsumata; Masataka Seike; Yoshiyuki Takei; Yoshifumi Takeyama; Susumu Eguchi; Sumio Watanabe; Hajime Isomoto; Hiroshi Yotsuyanagi; Takao Itoi; Tetsuo Takehara; Satoshi Mochida展开收起
作者单位
1. Guidelines Committee for Creating and Evaluating the “Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction‐Associated Steatotic Liver Disease 2026 (3rd Edition)” The Japanese Society of Gastroenterology/The Japan Society of Hepatology Tokyo Japan; 2. Department of Hepatology Toranomon Hospital 2‐2‐2 Tokyo Japan; 3. Department of Internal Medicine Institute of Gastroenterology, Tokyo Women’s Medical University 8‐1 Tokyo Japan; 4. The Japan Society of Hepatology Tokyo Japan展开收起
28
天
Ablation‐Based Salvage Strategy at Disease Progression After Initial Disease Control With Atezolizumab/Bevacizumab in Hepatocellular Carcinoma
作者
Kazuya Kariyama; Kazuhiro Nouso; Atsushi Hiraoka; Fujimasa Tada; Hideko Ohama; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Kazunari Tanaka; Kunihiko Tsuji; Ei Itobayashi; Akemi Tsutsui; Koichi Takaguchi; Michitaka Imai; Toru Ishikawa; Takeshi Hatanaka; Yuki Kanayama; Satoru Kakizaki; Atsushi Naganuma; Yoshihide Ueda; Tomomitsu Matono; Hideyuki Tamai; Junpei Okamura; Hironori Tanaka; Yutaka Yata; Akiko Wakuta; Masatoshi Kudo; Takashi Kumada展开收起
作者单位
1. Department of Gastroenterology Okayama City Hospital Okayama Japan; 2. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan; 3. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan; 4. Department of Internal Medicine Division of Gastroenterology Kobe University Graduate School of Medicine Kobe Japan; 5. Center for Gastroenterology Teine Keijinkai Hospital Sapporo Japan; 6. Department of Gastroenterology Asahi General Hospital Asahi Japan; 7. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan; 8. Department of Internal Medicine Niigata Cancer Center Hospital Niigata Japan; 9. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan; 10. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 11. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan; 12. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 13. Department of Gastroenterology Kakogawa City Hospital Kakogawa Japan; 14. Department of Gastroenterology Hyogo Prefectural Harima‐Himeji General Medical Center Himeji Japan; 15. Department of Hepatology Wakayama Rosai Hospital Wakayama Japan; 16. Department of Gastroenterology Takarazuka City Hospital Takarazuka Hyogo Japan; 17. Department of Gastroenterology Hanwa Memorial Hospital Osaka Japan; 18. Department of Gastroenterology and Hepatology Faculty of Medicine Kindai University Osaka Japan; 19. Department of Nursing Gifu Kyoritsu University Ogaki Japan展开收起
128
天
Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact
作者
Tomoko Tadokoro; Asahiro Morishita; Takushi Manabe; Hiroki Tai; Rie Yano; Mai Nakahara; Kyoko Oura; Koji Fujita; Shima Mimura; Joji Tani; Hideki Kobara展开收起
作者单位
1. Department of Gastroenterology and Neurology, Faculty of Medicine Kagawa University Kagawa Japan; 2. Department of Gastroenterology and Hepatology Takamatsu Red Cross Hospital Takamatsu Japan展开收起
50
天
From Genomic Instability to Epigenetic Signatures: The Evolving Landscape of Circulating Cell‐free DNA in Metabolic Dysfunction‐Associated Steatotic Liver Disease
作者
Wei‐Yue Lim; Rosmawati Mohamed; Yuh‐Fen Pung; Shamsul Mohd Zain展开收起
作者单位
1. Department of Pharmacology Faculty of Medicine Universiti Malaya Kuala Lumpur Malaysia; 2. Faculty of Medicine Universiti Kebangsaan Malaysia Kuala Lumpur Malaysia; 3. Division of Biomedical Science School of Pharmacy University of Nottingham Malaysia Semenyih Selangor Malaysia展开收起
101
天
Toward a Functional Cure for Chronic Hepatitis B: Current Landscape and Future Directions in Japan
作者
Yutaka Handa; Ethan Yichen Lee; Yasuhito Tanaka展开收起
作者单位
1. Specialty Care Medical Affairs, GSK Tokyo Japan; 2. Department of Gastroenterology and Hepatology, Faculty of Life Sciences Kumamoto University Kumamoto Japan展开收起
87
天
Clinical Characteristics, Predictive Factors, and the Impact of Antithrombotic Therapy on Bleeding Events in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
作者
Fujimasa Tada; Atsushi Hiraoka; Hideko Ohama; Toshifumi Tada; Masashi Hirooka; Kazuya Kariyama; Joji Tani; Masanori Atsukawa; Koichi Takaguchi; Ei Itobayashi; Shinya Fukunishi; Kunihiko Tsuji; Toru Ishikawa; Kazuto Tajiri; Hironori Tanaka; Hidenori Toyoda; Chikara Ogawa; Takashi Nishimura; Takeshi Hatanaka; Satoru Kakizaki; Kazuhito Kawata; Atsushi Naganuma; Hisashi Kosaka; Tomomitsu Matono; Yoshihide Ueda; Hidekatsu Kuroda; Yutaka Yata; Hiroki Nishikawa; Michitaka Imai; Tomoko Aoki; Hironori Ochi; Jumpei Okamura; Hideyuki Tamai; Shinichiro Nakamura; Yoshiko Nakamura; Osamu Yoshida; Kazuhiro Nouso; Asahiro Morishita; Norio Itokawa; Tomomi Okubo; Taeang Arai; Akemi Tsutsui; Takuya Nagano; Kazunari Tanaka; Yuichi Koshiyama; Yuki Kanayama; Hidenao Noritake; Shohei Komatsu; Takumi Fukumoto; Takanori Matsuura; Soo Ki Kim; Hirayuki Enomoto; Kosuke Matsui; Masaki Kaibori; Yoichi Hiasa; Masatoshi Kudo; Takashi Kumada; the Real‐life Practice Experts for HCC (RELPEC) Study Group and hepatocellular carcinoma experts from 48 clinics in Japan (HCC 48) Group展开收起
作者单位
1. Gastroenterology Center Ehime Prefectural Central Hospital Matsuyama Japan; 2. Division of Gastroenterology Department of Internal Medicine Kobe University Graduate School of Medicine Kobe Japan; 3. Department of Internal Medicine Japanese Red Cross Himeji Hospital Himeji Japan; 4. Department of Gastroenterology and Metabology Ehime University Graduate School of Medicine Toon Japan; 5. Department of Gastroenterology Okayama City Hospital Okayama Japan; 6. Department of Gastroenterology and Neurology Kagawa University Kagawa Japan; 7. Division of Gastroenterology and Hepatology Department of Internal Medicine Nippon Medical School Tokyo Japan; 8. Department of Hepatology Kagawa Prefectural Central Hospital Takamatsu Japan; 9. Department of Gastroenterology Asahi General Hospital Asahi Japan; 10. Department of Gastroenterology Hyogo Medical University Nishinomiya Japan; 11. Center for Gastroenterology Teine Keijinkai Hospital Sapporo Japan; 12. Department of Gastroenterology Saiseikai Niigata Hospital Niigata Japan; 13. Department of Gastroenterology Toyama University Hospital Toyama Japan; 14. Department of Gastroenterology Takarazuka City Hospital Hyogo Japan; 15. Department of Gastroenterology and Hepatology Ogaki Municipal Hospital Ogaki Japan; 16. Department of Gastroenterology Japanese Red Cross Takamatsu Hospital Takamatsu Japan; 17. Department of Gastroenterology Gunma Saiseikai Maebashi Hospital Maebashi Japan; 18. Department of Clinical Research NHO Takasaki General Medical Center Takasaki Japan; 19. Hepatology Division Department of Internal Medicine II Hamamatsu University School of Medicine Hamamatsu Japan; 20. Department of Gastroenterology NHO Takasaki General Medical Center Takasaki Japan; 21. Department of Hepatobiliary Surgery Kansai Medical University Hirakata Japan; 22. Department of Gastroenterology Hyogo Prefectural Harima‐Himeji General Medical Center Himeji Japan; 23. Department of Gastroenterology Kakogawa Central City Hospital Kakogawa Japan; 24. Division of Gastroenterology and Hepatology Department of Internal Medicine Iwate Medical University Iwate Japan; 25. Department of Gastroenterology Hanwa Memorial Hospital Osaka Japan; 26. Department of Gastroenterology Osaka Medical and Pharmaceutical University Osaka Japan; 27. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka Japan; 28. Center for Liver‐ Biliary‐Pancreatic Disease Matsuyama Red Cross Hospital Matsuyama Ehime Japan; 29. Department of Hepatology Wakayama Rosai Hospital Wakayama Japan; 30. Division of Hepato‐Biliary‐Pancreatic Surgery Department of Surgery Kobe University Graduate School of Medicine Kobe Japan; 31. Department of Gastroenterology Kobe Asahi Hospital Kobe Japan; 32. Gifu Kyoritsu University Ogaki Japan; 33. Department of Epidemiology, Infectious Disease Control, and Prevention Hiroshima University Institute of Biomedical and Health Sciences Hiroshima Japan展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天